Treue et al. [46] presented a systems analysis of cell lines in a model of EGFR-mutated non-small cell lung cancer (NSCLC) resistant to targeted therapy, the aim being to identify novel mechanisms of resistance and propose combination therapies. This evidence concerns the gene EGFR and non-small cell lung carcinoma.